FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078961502> ?p ?o ?g. }

• W2078961502 endingPage "176" @default.
• W2078961502 startingPage "170" @default.
• W2078961502 abstract "Purpose Single-fraction targeted radiation therapy delivered by the Leksell Gamma Knife system is a minimally invasive treatment option for choroidal melanoma that has been used as an alternative to enucleation, proton beam therapy, or brachytherapy. Previously reported Gamma Knife series involved the treatment of choroidal melanomas with a dose of 40 to 50 Gy at the tumor margin. We report our institutional experience using a significantly lower dose. Methods and Materials Fourteen patients with choroidal melanoma were treated with the Leksell Gamma Knife at our institution over a 7-year period. The treatment and clinical data were analyzed in a retrospective fashion after a mean follow-up of 32.2 months. Results The mean dose to the tumor margin was 22.2 ± 2.4 Gy (range, 20– 25 Gy). Mean treated tumor volume was 1.1 ± 1.2 cc. Local control was achieved in 13 cases (93%). In 1 patient both intraocular spread and distant metastatic disease developed after treatment. Visual function of the affected eye was preserved in 5 patients (36%) at latest follow-up, in 9 patients (64%) visual loss ensued. Mild to moderate radiation toxicity developed in 8 patients. Conclusions Choroidal melanoma can be safely and effectively treated using Leksell Gamma Knife stereotactic radiosurgery with a marginal dose of less than 25 Gy. Single-fraction targeted radiation therapy delivered by the Leksell Gamma Knife system is a minimally invasive treatment option for choroidal melanoma that has been used as an alternative to enucleation, proton beam therapy, or brachytherapy. Previously reported Gamma Knife series involved the treatment of choroidal melanomas with a dose of 40 to 50 Gy at the tumor margin. We report our institutional experience using a significantly lower dose. Fourteen patients with choroidal melanoma were treated with the Leksell Gamma Knife at our institution over a 7-year period. The treatment and clinical data were analyzed in a retrospective fashion after a mean follow-up of 32.2 months. The mean dose to the tumor margin was 22.2 ± 2.4 Gy (range, 20– 25 Gy). Mean treated tumor volume was 1.1 ± 1.2 cc. Local control was achieved in 13 cases (93%). In 1 patient both intraocular spread and distant metastatic disease developed after treatment. Visual function of the affected eye was preserved in 5 patients (36%) at latest follow-up, in 9 patients (64%) visual loss ensued. Mild to moderate radiation toxicity developed in 8 patients. Choroidal melanoma can be safely and effectively treated using Leksell Gamma Knife stereotactic radiosurgery with a marginal dose of less than 25 Gy." @default.
• W2078961502 created "2016-06-24" @default.
• W2078961502 creator A5002623840 @default.
• W2078961502 creator A5018213798 @default.
• W2078961502 creator A5042660769 @default.
• W2078961502 creator A5045996317 @default.
• W2078961502 creator A5053414244 @default.
• W2078961502 creator A5062921168 @default.
• W2078961502 creator A5065909147 @default.
• W2078961502 creator A5067467531 @default.
• W2078961502 date "2009-09-01" @default.
• W2078961502 modified "2023-09-28" @default.
• W2078961502 title "Dose De-Escalation With Gamma Knife Radiosurgery in the Treatment of Choroidal Melanoma" @default.
• W2078961502 cites W1974606008 @default.
• W2078961502 cites W1978099645 @default.
• W2078961502 cites W1980404110 @default.
• W2078961502 cites W1995835953 @default.
• W2078961502 cites W2024094142 @default.
• W2078961502 cites W2027879900 @default.
• W2078961502 cites W2029874986 @default.
• W2078961502 cites W2034911396 @default.
• W2078961502 cites W2044112280 @default.
• W2078961502 cites W2044437751 @default.
• W2078961502 cites W2056453159 @default.
• W2078961502 cites W2057801728 @default.
• W2078961502 cites W2062242147 @default.
• W2078961502 cites W2064646690 @default.
• W2078961502 cites W2065063530 @default.
• W2078961502 cites W2066348781 @default.
• W2078961502 cites W2073149051 @default.
• W2078961502 cites W2075860094 @default.
• W2078961502 cites W2080929565 @default.
• W2078961502 cites W2087340816 @default.
• W2078961502 cites W2090047083 @default.
• W2078961502 cites W2097512974 @default.
• W2078961502 cites W2099187338 @default.
• W2078961502 cites W2105269005 @default.
• W2078961502 cites W2118400152 @default.
• W2078961502 cites W2119860530 @default.
• W2078961502 cites W2163106161 @default.
• W2078961502 cites W2164142138 @default.
• W2078961502 cites W2419528605 @default.
• W2078961502 cites W2603643693 @default.
• W2078961502 cites W33364968 @default.
• W2078961502 cites W37292458 @default.
• W2078961502 cites W4239509499 @default.
• W2078961502 cites W4242987572 @default.
• W2078961502 cites W4244457251 @default.
• W2078961502 cites W4250995170 @default.
• W2078961502 cites W4253473049 @default.
• W2078961502 cites W4253975669 @default.
• W2078961502 cites W4254282631 @default.
• W2078961502 cites W58796604 @default.
• W2078961502 doi "https://doi.org/10.1016/j.ijrobp.2008.10.077" @default.
• W2078961502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19286331" @default.
• W2078961502 hasPublicationYear "2009" @default.
• W2078961502 type Work @default.
• W2078961502 sameAs 2078961502 @default.
• W2078961502 citedByCount "29" @default.
• W2078961502 countsByYear W20789615022012 @default.
• W2078961502 countsByYear W20789615022013 @default.
• W2078961502 countsByYear W20789615022014 @default.
• W2078961502 countsByYear W20789615022016 @default.
• W2078961502 countsByYear W20789615022017 @default.
• W2078961502 countsByYear W20789615022018 @default.
• W2078961502 countsByYear W20789615022019 @default.
• W2078961502 countsByYear W20789615022020 @default.
• W2078961502 countsByYear W20789615022021 @default.
• W2078961502 countsByYear W20789615022022 @default.
• W2078961502 countsByYear W20789615022023 @default.
• W2078961502 crossrefType "journal-article" @default.
• W2078961502 hasAuthorship W2078961502A5002623840 @default.
• W2078961502 hasAuthorship W2078961502A5018213798 @default.
• W2078961502 hasAuthorship W2078961502A5042660769 @default.
• W2078961502 hasAuthorship W2078961502A5045996317 @default.
• W2078961502 hasAuthorship W2078961502A5053414244 @default.
• W2078961502 hasAuthorship W2078961502A5062921168 @default.
• W2078961502 hasAuthorship W2078961502A5065909147 @default.
• W2078961502 hasAuthorship W2078961502A5067467531 @default.
• W2078961502 hasConcept C126838900 @default.
• W2078961502 hasConcept C141071460 @default.
• W2078961502 hasConcept C188261085 @default.
• W2078961502 hasConcept C2777416452 @default.
• W2078961502 hasConcept C2777658100 @default.
• W2078961502 hasConcept C2780387249 @default.
• W2078961502 hasConcept C2910410966 @default.
• W2078961502 hasConcept C2989005 @default.
• W2078961502 hasConcept C2994042627 @default.
• W2078961502 hasConcept C3019556204 @default.
• W2078961502 hasConcept C502942594 @default.
• W2078961502 hasConcept C509974204 @default.
• W2078961502 hasConcept C71924100 @default.
• W2078961502 hasConceptScore W2078961502C126838900 @default.
• W2078961502 hasConceptScore W2078961502C141071460 @default.
• W2078961502 hasConceptScore W2078961502C188261085 @default.
• W2078961502 hasConceptScore W2078961502C2777416452 @default.
• W2078961502 hasConceptScore W2078961502C2777658100 @default.
• W2078961502 hasConceptScore W2078961502C2780387249 @default.

• next